FDA Inspection 1293216 — Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd
The FDA completed an inspection of Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd on October 24, 2025 in Jinhua. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinhua (China)